236 related articles for article (PubMed ID: 32519226)
21. Proton pump inhibitor for non-erosive reflux disease: a meta-analysis.
Zhang JX; Ji MY; Song J; Lei HB; Qiu S; Wang J; Ai MH; Wang J; Lv XG; Yang ZR; Dong WG
World J Gastroenterol; 2013 Dec; 19(45):8408-19. PubMed ID: 24363534
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
23. Response of regurgitation to proton pump inhibitor therapy in clinical trials of gastroesophageal reflux disease.
Kahrilas PJ; Howden CW; Hughes N
Am J Gastroenterol; 2011 Aug; 106(8):1419-25; quiz 1426. PubMed ID: 21537361
[TBL] [Abstract][Full Text] [Related]
24. Medical treatments of GERD: the old and new.
Vela MF
Gastroenterol Clin North Am; 2014 Mar; 43(1):121-33. PubMed ID: 24503363
[TBL] [Abstract][Full Text] [Related]
25. Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis.
Sun S; Cui Z; Zhou M; Li R; Li H; Zhang S; Ba Y; Cheng G
Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27577963
[TBL] [Abstract][Full Text] [Related]
26. Randomized controlled trial comparing the efficacy of mosapride plus omeprazole combination therapy to omeprazole monotherapy in gastroesophageal reflux disease.
Yamaji Y; Isomura Y; Yoshida S; Yamada A; Hirata Y; Koike K
J Dig Dis; 2014 Sep; 15(9):469-76. PubMed ID: 24957863
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.
Richter JE; Kumar A; Lipka S; Miladinovic B; Velanovich V
Gastroenterology; 2018 Apr; 154(5):1298-1308.e7. PubMed ID: 29305934
[TBL] [Abstract][Full Text] [Related]
28. A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease.
Hillman L; Yadlapati R; Thuluvath AJ; Berendsen MA; Pandolfino JE
Dis Esophagus; 2017 Sep; 30(9):1-15. PubMed ID: 28859358
[TBL] [Abstract][Full Text] [Related]
29. Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.
Kung YM; Hsu WH; Wu MC; Wang JW; Liu CJ; Su YC; Kuo CH; Kuo FC; Wu DC; Wang YK
Dig Dis Sci; 2017 Dec; 62(12):3298-3316. PubMed ID: 29110162
[TBL] [Abstract][Full Text] [Related]
30. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis.
Leiman DA; Riff BP; Morgan S; Metz DC; Falk GW; French B; Umscheid CA; Lewis JD
Dis Esophagus; 2017 May; 30(5):1-9. PubMed ID: 28375448
[TBL] [Abstract][Full Text] [Related]
31. Direct Comparison of the Efficacy and Safety of Vonoprazan Versus Proton-Pump Inhibitors for Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.
Cheng Y; Liu J; Tan X; Dai Y; Xie C; Li X; Lu Q; Kou F; Jiang H; Li J
Dig Dis Sci; 2021 Jan; 66(1):19-28. PubMed ID: 32095968
[TBL] [Abstract][Full Text] [Related]
32. Virtue of adding prokinetics to proton pump inhibitors in the treatment of laryngopharyngeal reflux disease: prospective study.
Ezzat WF; Fawaz SA; Fathey H; El Demerdash A
J Otolaryngol Head Neck Surg; 2011 Aug; 40(4):350-6. PubMed ID: 21777555
[TBL] [Abstract][Full Text] [Related]
33. Systematic review with network meta-analysis: indirect comparison of the efficacy of vonoprazan and proton-pump inhibitors for maintenance treatment of gastroesophageal reflux disease.
Miwa H; Igarashi A; Teng L; Uda A; Deguchi H; Tango T
J Gastroenterol; 2019 Aug; 54(8):718-729. PubMed ID: 30919071
[TBL] [Abstract][Full Text] [Related]
34. Gastroesophageal reflux disease-related symptom recurrence in patients discontinuing proton pump inhibitors for Bravo
Schey R; Alla SP; Midani D; Parkman HP
Rev Gastroenterol Mex; 2017; 82(4):277-286. PubMed ID: 28385467
[TBL] [Abstract][Full Text] [Related]
35. Gastro-oesophageal reflux disease: beyond proton pump inhibitor therapy.
Hershcovici T; Fass R
Drugs; 2011 Dec; 71(18):2381-9. PubMed ID: 22117130
[TBL] [Abstract][Full Text] [Related]
36. Adverse effects reported in the use of gastroesophageal reflux disease treatments in children: a 10 years literature review.
Cohen S; Bueno de Mesquita M; Mimouni FB
Br J Clin Pharmacol; 2015 Aug; 80(2):200-8. PubMed ID: 25752807
[TBL] [Abstract][Full Text] [Related]
37. Optimal management of severe symptomatic gastroesophageal reflux disease.
Talley NJ; Zand Irani M
J Intern Med; 2021 Feb; 289(2):162-178. PubMed ID: 32691466
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness and safety of proton pump inhibitors in infantile gastroesophageal reflux disease.
Higginbotham TW
Ann Pharmacother; 2010 Mar; 44(3):572-6. PubMed ID: 20124466
[TBL] [Abstract][Full Text] [Related]
39. Nissen fundoplication
Zhang C; Hu ZW; Yan C; Wu Q; Wu JM; Du X; Liu DG; Luo T; Li F; Wang ZG
World J Gastroenterol; 2017 May; 23(19):3546-3555. PubMed ID: 28596691
[TBL] [Abstract][Full Text] [Related]
40. Combination drug therapy for gastroesophageal reflux disease.
Cross LB; Justice LN
Ann Pharmacother; 2002 May; 36(5):912-6. PubMed ID: 11978171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]